TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/12/21 16:02 | 7/8/21 | GBIO | Generation Bio Co. | DE | Health | Drug | Pharmaceutical Preparations | Kerr Douglas | MA | O | CHIEF ME | S.d | -89 | 25.20 | 0 | -4 | -1 | 327 | D | ||||||||||||||
4/7/21 16:05 | 4/5/21 | GBIO | Generation Bio Co. | DE | Health | Drug | Pharmaceutical Preparations | Kerr Douglas | MA | O | CHIEF ME | S.d | -423 | 30.09 | 0 | -14 | -4 | 327 | D | ||||||||||||||
3/9/21 16:05 | 3/5/21 | GBIO | Generation Bio Co. | DE | Health | Drug | Pharmaceutical Preparations | Kerr Douglas | MA | O | CHIEF ME | S.d | -354 | 31.44 | 0 | -11 | -3 | 327 | D | ||||||||||||||
2/10/21 16:05 | 2/8/21 | GBIO | Generation Bio Co. | DE | Health | Drug | Pharmaceutical Preparations | Kerr Douglas | MA | O | CHIEF ME | S.d | -376 | 33.37 | 0 | -11 | -3 | 327 | D | ||||||||||||||
1/13/21 16:07 | 1/11/21 | GBIO | Generation Bio Co. | DE | Health | Drug | Pharmaceutical Preparations | Kerr Douglas | MA | O | CHIEF ME | S.d | -311 | 27.58 | 0 | -11 | -3 | 327 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |